IREN: Delivery and Financing Terms Matter More Than AI Growth
Analysis date
Published
MW GOBLIN · AI company research
The stance is wait-and-see as of 2026-11-12. The AI transition has been demonstrated in revenue, but operational delays and the financing terms for 6000000000 USD in subsequent expansion funding will determine per-share returns. Even at $20.11, revenue growth alone is insufficient to establish confidence in undervaluation.
Toss Securities
Quote November 12, 2026 at 13:10 KST
Retrieved November 12, 2026 at 13:10 KST
IREN Limited stock price chart
Up to 400 recent daily candles · 20, 60, and 120-day moving averages
Loading daily chart…
Uses completed candles collected by learning_trading. Prices may extend beyond the report's analysis date.
AI Revenue Expands, but Profitability Will Take Time
AI revenue for July–September 2026 was $200000000, up 182% from the previous quarter. However, the target for bringing capacity online to support more than $4000000000 in annualized revenue was pushed back to January–February 2027 because of customer design changes and supply delays. This is a company target, not recognized revenue. Management expects approximately $250000000 in AI revenue for October–December and an increase of $50000000–60000000 in cash operating expenses, making it difficult for revenue growth to translate immediately into higher profits. [1][2][3]
Distinguish Customer Prepayments from Shareholder Returns
Customer prepayments reduce the investment burden but differ from internally generated cash. Operating cash flow of $529000000 in the same quarter included a $645000000 increase in deferred revenue, while spending on facilities and computers was $4824000000. Of the $15000000000 in remaining FY27 investment, financing for $6000000000 remains unconfirmed. With an additional 17370000 shares issued since the end of September, borrowing costs and dilution from equity issuance could reduce shareholders' share of growth. [1][2]
The Financing Burden Still Requires Scrutiny Against Revenue After Growth
At $20.11, using 424000000 shares as of October 30 day and net debt of $6690000000 at the end of September (including finance leases and excluding restricted cash), the indicative EV is $15220000000. This represents 6.0–6.4 x relative to revenue forecasts from different institutions of $2390000000–2520000000 for FY27 (ending June 2027), and the comparison combines different reference dates. Because operational delays and unconfirmed financing costs and dilution are difficult to reflect precisely, conviction in undervaluation and a price target are withheld. [1][4][5]
What could change the thesis
- Customer acceptance in January–February 2027 and whether operating ARR exceeds $4000000000 will change revenue estimates. Further delays or contractual compensation costs would prompt downward revisions.
- The interest rates, prepayments, and number of new shares associated with the additional $6000000000 will determine per-share value. The assessment would improve if dilution is contained and cash flow after investment improves.
Sources and Evidence
- IREN FY27 Q1 10-Q ↗2026-11-05 · Cover, financial statements, and notes 19 and 25
- IREN FY27 Q1 earnings release ↗2026-11-05 · Pages 1–3: results, investment plans, and notes
- IREN earnings call and Q&A, Motley Fool/Webull ↗2026-11-05 earnings call · CFO outlook; delivery and financing Q&A
- Stock Analysis and S&P Global forecasts ↗Updated 2026-11-10 · FY2027 forecasts and data providers
- TIKR forecast revisions and reporting on JPMorgan ↗2026-11-10 · FY2027 revenue estimate revisions
This AI-generated report is for information. Check the analysis date and primary sources. Terms